Biotech · Private company
Vifor Pharma, Inc.
Track this companyFree. Adds Vifor Pharma, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials51 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- PatiromerPhase 3 · HyperkalemiaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Effect of Patiromer in Children Under 12 Years of Age With High Blood Potassium LevelsPHASE2 · RECRUITING · started Apr 6, 2025ClinicalTrials.gov NCT05766839 · fetched Nov 12, 2026
- Pragmatic Trial Of Alerts for Use of Mineralocorticoid Receptor AntagonistsNA · COMPLETED · started Nov 3, 2021ClinicalTrials.gov NCT04903717 · fetched Nov 12, 2026
- Patiromer Efficacy to Reduce Episodic Hyperkalemia in End Stage Renal Disease PatientsPHASE4 · COMPLETED · started Jun 20, 2019ClinicalTrials.gov NCT03781089 · fetched Nov 12, 2026
- Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (DIAMOND)PHASE3 · COMPLETED · started Apr 24, 2019ClinicalTrials.gov NCT03888066 · fetched Nov 12, 2026
- Pharmacodynamic & Safety of Patiromer in Children & Adolescents (2-<18 Yrs) With Chronic Kidney Disease and HyperkalemiaPHASE2 · TERMINATED · started Jul 7, 2017ClinicalTrials.gov NCT03087058 · fetched Nov 12, 2026